Skip to content
Home/Companies/MedTech/NAMSA
NA

NAMSA

MedTech·US·Active·6yr hold

NAMSA is a MedTech company, headquartered in United States.

Entry
2020
Hold
6yr
Status
Active
Est. EV
–

Who owns NAMSA?

NAMSA is currently owned by ARCHIMED through MED Platform I (2019 vintage), since 2020. Across its history, NAMSA has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

ARCHIMED
Most recent investor
ARCHIMED
MED Platform I · 2019 · Buyout
2 ownership periods · full history below

Key facts

HQUnited States
SectorMedTech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by Omnes Capital and ARCHIMED since 2020.
Co-invest · 2 holders · 2020 · present
Omnes Capital
Omnes CapitalActive
2020 · present · Omnes Co-Investment · 2008 · Buyout
MOIC
–
ARCHIMED
ARCHIMEDActive
2020 · present · MED Platform I · 2019 · Buyout
MOIC
–

More from MED Platform I

Other portfolio companies in the same fund.

CARSO
Active
MedTechFrance· 2021
Ad-Tech Medical Instrument
Exited 2024
MedTechUS· 2020
to
Ametris (ActiGraph)
Exited 2026
HealthTechUS· 2020
to
ZYTOMICS
Active
MedTechGermany· 2020
Bomi Group
Exited 2023
MedTechItaly· 2019
to
DIESSE
Exited 2025
MedTechItaly· 2019
to

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
APEX Digital
Active
Generis Capital PartnersFrance· 2025
Data refreshed weekly · Sourced from public filings